Security key
86150R107
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)
CUSIP: 86150R107
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 58,810,778
- Total 13F shares
- 67,691,438
- Share change
- +2,134,051
- Total reported value
- $1,574,062,054
- Put/Call ratio
- 18%
- Price per share
- $23.50
- Number of holders
- 151
- Value change
- +$64,324,837
- Number of buys
- 83
- Number of sells
- 62
Report period
Q3 2025
Institutions
151
Top holders
10
STOK full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
6.8%
|
3,732,540
|
$87,769,558 | +$14,428,761 | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
6.5%
from 13D/G
|
3,573,976
|
$40,564,628 | — | 30 Jun 2025 | |
| BlackRock Portfolio Management LLC |
13D/G
|
— |
4.7%
|
2,550,341
|
$28,946,115 | -$2,192,358 | 30 Jun 2025 | |
| Skorpios Trust |
3/4/5
13D/G
13F
|
10%+ Owner · Montrago Trustees Ltd · Company |
4.1%
from 13D/G
|
3,906,181
|
$39,843,046 | -$30,600,000 | 04 Jun 2025 | |
| FMR LLC |
13F
|
Company |
13%
|
7,412,982
|
$84,137,345 | — | 30 Jun 2025 | |
| Lynx1 Capital Management LP |
13F
|
Company |
9.2%
|
5,404,674
|
$61,343,050 | — | 30 Jun 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
8.7%
|
5,123,525
|
$58,152,009 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
7.9%
|
4,633,838
|
$52,594,061 | — | 30 Jun 2025 | |
| Redmile Group, LLC |
13F
|
Company |
7.4%
|
4,375,931
|
$49,666,817 | — | 30 Jun 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
5.4%
|
3,173,258
|
$36,016,478 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
2,946,258
|
$33,440,028 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
3.9%
|
2,300,554
|
$26,111,286 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
3.8%
|
2,247,347
|
$25,507,388 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
1,487,156
|
$16,879,221 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.2%
|
1,301,381
|
$14,770,674 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
972,921
|
$11,044,249 | — | 30 Jun 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.5%
|
883,646
|
$10,029,382 | — | 30 Jun 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1.3%
|
789,698
|
$8,963,072 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
673,884
|
$7,649,908 | — | 30 Jun 2025 | |
| Corient Private Wealth LLC |
13F
|
Company |
1.1%
|
659,834
|
$7,489,116 | — | 30 Jun 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
0.96%
|
562,120
|
$6,380,062 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.93%
|
548,090
|
$6,220,821 | — | 30 Jun 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.91%
|
537,973
|
$6,105,994 | — | 30 Jun 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.91%
|
532,413
|
$6,042,888 | — | 30 Jun 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.85%
|
501,972
|
$5,697,382 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.85%
|
500,000
|
$5,675,000 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
423,554
|
$4,807,338 | — | 30 Jun 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.67%
|
396,000
|
$4,513,080 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.6%
|
352,715
|
$4,003,315 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.58%
|
340,779
|
$3,867,842 | — | 30 Jun 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.43%
|
254,161
|
$2,884,727 | — | 30 Jun 2025 | |
| Birchview Capital, LP |
13F
|
Company |
0.36%
|
210,000
|
$2,383,500 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.3%
|
174,714
|
$1,983,002 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.24%
|
144,063
|
$1,635,000 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.24%
|
139,900
|
$1,587,864 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.23%
|
137,066
|
$1,555,700 | — | 30 Jun 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.22%
|
129,571
|
$1,470,631 | — | 30 Jun 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.21%
|
126,350
|
$1,434,073 | — | 30 Jun 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.21%
|
125,861
|
$1,428,522 | — | 30 Jun 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.21%
|
123,482
|
$1,401,521 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.18%
|
107,240
|
$1,217,174 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
103,773
|
$1,177,823 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
103,244
|
$1,171,820 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.17%
|
102,468
|
$1,163,012 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.16%
|
95,120
|
$1,079,612 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.14%
|
81,395
|
$923,833 | — | 30 Jun 2025 | |
| Fort Point Capital Partners LLC |
13F
|
Company |
0.13%
|
75,434
|
$856,176 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.11%
|
66,419
|
$753,847 | — | 30 Jun 2025 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
62,000
|
$703,700 | — | 30 Jun 2025 | |
| Kennondale Capital Management LLC |
13F
|
Company |
0.1%
|
61,183
|
$694,427 | — | 30 Jun 2025 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) as of Q3 2025
As of 30 Sep 2025,
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,691,438 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., Lynx1 Capital Management LP, RTW INVESTMENTS, LP, BAKER BROS. ADVISORS LP, Redmile Group, LLC, MORGAN STANLEY, TORONTO DOMINION BANK, VANGUARD GROUP INC, and Skorpios Trust.
This page lists
151
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
133
Q3 2025 holders
151
Holder diff
18
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.